IRCT20151020024625N19招募中3 期
Comparison of the efficacy and safety of rivaroxaban and heparin and enoxaparin as thromboprophylaxis agents for gynecology oncologic surgery
Semnan University of Medical Sciences0 个研究点目标入组 90 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 90
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- Female
入选标准
- •Candidates for gynecologic oncologic surgery
排除标准
- •Receiving anticoagulants agents at present
- •Contraindication for anticoagulants
- •Uncontrolled cardiovascular and cerebrovascular diseases
研究者
相似试验
招募中
2 期
Efficiency of rivaroxaban and enoxaparin in the prevention of venous thromboembolic eventsSpinal fusion.Osseous stenosis of neural canalM99.3IRCT20120527009878N16Tabriz University of Medical Sciences60
招募中
3 期
Efficacy and safety of rivaroxaban and subcutaneous enoxaparin after spinal surgeryIntravenous thromboembolism.Thromboembolism in the puerperiumO88.23IRCT20211109053014N1Esfahan University of Medical Sciences200
招募中
2 期
Evaluating the efficacy and safety of rivaroxaban comparing to warfarin in patients with chronic thromboembolic pulmonary hypertension (CTEPH) following endartrectomy surgeryChronic Thrombo Embolic Pulmonary Hypertension(CTEPH).Chronic Thromboembolic Pulmonary Hypertension.I27. 24IRCT20151227025726N22Shahid Beheshti University of Medical Sciences96
招募中
2 期
The effect of rivaroxaban on hearing lossDecreased sensorineural hearing.Unspecified sensorineural hearing lossH90.5IRCT20110603006699N5Esfahan University of Medical Sciences34
已完成
2 期
Effect of rivaroxaban in radial artery thrombosisIRCT20200111046084N1Rajaie Cardiovascular Medical and Research Center40